Rallybio Co. (NASDAQ:RLYB) Receives $12.20 Consensus Target Price from Brokerages

Shares of Rallybio Co. (NASDAQ:RLYB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among […]

Leave a Reply

Your email address will not be published.

Previous post Graco (NYSE:GGG) Shares Gap Down on Disappointing Earnings
Next post Corus Entertainment Inc. (TSE:CJR.B) Receives C$0.94 Consensus PT from Analysts